Price$1.56+0.31 (+25.20%)
01:45 PM07:45 PM
News · 26 weeks23+300%
2025-10-262026-04-19
Mix1490d
- Insider8(57%)
- Other4(29%)
- SEC Filings2(14%)
Latest news
25 items- SECSEC Form RW filed by Amesite Inc.RW - Amesite Inc. (0001807166) (Filer)
- SECAmesite Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Amesite Inc. (0001807166) (Filer)
- SECSEC Form DEL AM filed by Amesite Inc.DEL AM - Amesite Inc. (0001807166) (Filer)
- SECSEC Form S-1 filed by Amesite Inc.S-1 - Amesite Inc. (0001807166) (Filer)
- INSIDERSEC Form 4 filed by Omenn Gilbert S4 - Amesite Inc. (0001807166) (Issuer)
- INSIDERSEC Form 4 filed by Brewer Barbie4 - Amesite Inc. (0001807166) (Issuer)
- INSIDERSEC Form 4 filed by Parmer George4 - Amesite Inc. (0001807166) (Issuer)
- INSIDERSEC Form 4 filed by Losh J Michael4 - Amesite Inc. (0001807166) (Issuer)
- PRAmesite Executes Trading Partner Agreement Enabling Secure Connectivity with Leading Homecare Technology PlatformDETROIT, March 26, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced that it has entered into an Electronic Transactions Trading Partner Agreement with a leading homecare technology platform company, that processes tens of billions of dollars in homecare services annually. The Agreement establishes Amesite as a compliant trading partner, in accordance with HIPAA and applicable regulations. Under the Agreement, Amesite is authorized to securely connect NurseMagic™ to a leading electronic transaction infrastructure as a healthcare data submitter. This integration allows NurseMagic™ to streamline c
- PRAmesite's NurseMagic™ Named Finalist for Nurse.org "Best of Nursing: AI Nursing Tool" AwardDETROIT, March 04, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST) today announced that its AI-powered healthcare platform, NurseMagic™, has been named a finalist in Nurse.org's "Best of Nursing Awards" in the AI Nursing Tool category. The recognition from one of the largest online nursing communities comes less than two years after launch and as Amesite scales NurseMagic™ into the U.S. post-acute care market, which recent analyses estimate at roughly $460–510 billion in 2025 and project to reach more than $800 billion by 2035. Clinicians in post-acute care spend a significant share of their time on documentation and administrative tasks that are essential for reimbursement and compli
- INSIDERSEC Form 4 filed by Director Losh J Michael4 - Amesite Inc. (0001807166) (Issuer)
- INSIDERSEC Form 4 filed by Director Omenn Gilbert S4 - Amesite Inc. (0001807166) (Issuer)
- INSIDERSEC Form 4 filed by Director Parmer George4 - Amesite Inc. (0001807166) (Issuer)
- INSIDERSEC Form 4 filed by Director Brewer Barbie4 - Amesite Inc. (0001807166) (Issuer)
- INSIDERSEC Form 4 filed by Director Brewer Barbie4 - Amesite Inc. (0001807166) (Issuer)
- INSIDERSEC Form 4 filed by Director Omenn Gilbert S4 - Amesite Inc. (0001807166) (Issuer)
- INSIDERSEC Form 4 filed by Director Parmer George4 - Amesite Inc. (0001807166) (Issuer)
- INSIDERSEC Form 4 filed by Director Losh J Michael4 - Amesite Inc. (0001807166) (Issuer)
- PRAmesite Accelerates Growth With Launch of AI-Native NurseMagic™ EMRDETROIT, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST) today announced the launch of the NurseMagic™ EMR, marking a significant expansion of the Company's platform following a year of strong sequential revenue growth and enterprise traction. The AI-native, modular EMR extends NurseMagic™ from a point-of-care solution into core post-acute care infrastructure, supporting both coexistence with legacy systems and full system replacement. Amesite expects to begin onboarding EMR customers in January 2026. Amesite's revenue growth has occurred in clear step changes aligned with the rollout of progressively higher-value product tiers, progressing from Individual to Teams, Teams+, a
- SECAmesite Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Amesite Inc. (0001807166) (Filer)
- PRAmesite Announces 69% QoQ Revenue Increase in Q2 2026 and Product Plans for Coming MonthsDETROIT, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST), a leading developer of AI-powered enterprise solutions, announces a 69% QoQ increase in revenue even as it reduced its spending. Amesite also reported expanding its customer base and offerings to post-acute health businesses across the U.S. The Company described these results and its pathway to offer the first AI-powered electronic medical record (EMR) by 2026 in a shareholder update made available yesterday on its website. As part of the shareholder update, Amesite Founder & CEO, Dr. Ann Marie Sastry discussed: Summary of FY 2025 10-K and Q1 2026 10-Q: Financial performance was described in the context of methodical
- SECAmesite Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Amesite Inc. (0001807166) (Filer)
- SECAmendment: SEC Form 10-K/A filed by Amesite Inc.10-K/A - Amesite Inc. (0001807166) (Filer)
- SECSEC Form 10-Q filed by Amesite Inc.10-Q - Amesite Inc. (0001807166) (Filer)
- INSIDERSEC Form 4 filed by Director Brewer Barbie4 - Amesite Inc. (0001807166) (Issuer)